Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $14 Million - $27.6 Million
-4,807,557 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$2.56 - $5.49 $7.53 Million - $16.2 Million
-2,942,443 Reduced 37.97%
4,807,557 $26.4 Million
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $2.02 Million - $3.94 Million
750,000 Added 10.71%
7,750,000 $21.1 Million
Q4 2020

Feb 16, 2021

SELL
$3.17 - $4.49 $4.76 Million - $6.74 Million
-1,500,000 Reduced 17.65%
7,000,000 $22.3 Million
Q3 2020

Nov 16, 2020

SELL
$2.98 - $5.2 $7.45 Million - $13 Million
-2,500,000 Reduced 22.73%
8,500,000 $34 Million
Q2 2020

Aug 14, 2020

SELL
$2.29 - $4.24 $2.69 Million - $4.98 Million
-1,174,486 Reduced 9.65%
11,000,000 $43.2 Million
Q1 2020

May 15, 2020

BUY
$1.92 - $4.39 $23.4 Million - $53.4 Million
12,174,486 New
12,174,486 $29.8 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.